Methylation of RAS association domain family protein 1A as a biomarker of lung cancer
Abstract
BACKGROUND Promoter hypermethylation is an important mechanism for silencing tumor‐suppressor genes in cancer and a promising tool for development of molecular biomarkers. This study aimed to determine the prevalence of RAS association domain family protein 1A (RASSF1A) promoter hypermethylation in bronchial aspirates of patients with suspected lung cancer and to test whether this type of methylation assay could be used as a diagnostic adjunct to conventional cytology. METHODS Two hundred three bronchial aspirates from patients with suspected lung cancer were analyzed for RASSF1A hypermethylation by using a sensitive quantitative methylation‐specific polymerase chain reaction (QMSP). RESULTS RASSF1A hypermethylation was found in 88% (35 of 40), 28% (31 of 111), and 100% (6 of 6) of bronchial aspirates collected from patients diagnosed with small cell lung cancer, nonsmall cell lung cancer, and combined small cell lung cancer, respectively. No hypermethylation was detected in patients diagnosed with nonneoplastic lung disease (0 of 46). Depending on histologic subtype, up to 82% of cases presenting with a negative histology showed a positive methylation assay. CONCLUSIONS The QMSP analysis of RASSF1A hypermethylation enabled a highly specific distinction between patients diagnosed with lung cancer and those with nonneoplastic lung disease. These results suggested that a QMSP assay is a promising molecular tool for diagnosis of primary lung cancer. Cancer (Cancer Cytopathol) 2006. © 2006 American Cancer Society.Keywords
This publication has 24 references indexed in Scilit:
- Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung CancerClinical Cancer Research, 2004
- Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokersInternational Journal of Cancer, 2003
- Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patientsOncogene, 2003
- DNA Extraction from Bronchial Aspirates for Molecular Cytology: Which Method to Take?Analytical Cellular Pathology, 2003
- The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomasOncogene, 2001
- Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursOncogene, 2001
- Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3Nature Genetics, 2000
- Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancerNature, 1987
- Loss of heterozygosity of chromosome 3p markers in small-cell lung cancerNature, 1987
- Specific Chromosome Defect Associated with Human Small-Cell Lung Cancer: Deletion 3p(14-23)Science, 1982